{"schema_version":"1","generated_at":"2026-10-29T07:07:28.639Z","data_as_of":null,"url":"https://www.findmykol.com/kol/katherine-weilbaecher","json_url":"https://www.findmykol.com/kol/katherine-weilbaecher/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"katherine-weilbaecher","name":"Katherine Weilbaecher","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Saint Louis","state":"MO","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1447277942","orcid":"0000-0002-7137-4742","openalex":"A5063285199"},"summary":"Katherine Weilbaecher is an Oncology physician. OpenAlex indexes 459 publications with 9,290 citations (h-index 55); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":459,"cited_by_count":9290,"h_index":55,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00263211","title":"A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Washington University School of Medicine","source_url":"https://clinicaltrials.gov/study/NCT00263211","trial_url":"https://www.findmykol.com/trial/NCT00263211"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"Gilead Sciences, Inc.","program_year":2023,"amount_usd":72.21,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1447277942"},{"payer":"Amgen Inc.","program_year":2022,"amount_usd":21.16,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1447277942"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1447277942","source":"payments"},"funding":{"award_count":6,"fiscal_years":{"first":2000,"last":2026},"rows_total":26,"shown":3,"withheld":23,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R01CA297167","title":"Mechanism of acid signaling in bone organ metastases on tumor and myeloid cell evolution towards immune suppression and tumor progression","fiscal_year":2026,"amount_usd":"645322","organization":"WASHINGTON UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01CA297167"},{"project":"R01CA297167","title":"Mechanism of acid signaling in bone organ metastases on tumor and myeloid cell evolution towards immune suppression and tumor progression","fiscal_year":2025,"amount_usd":"645323","organization":"WASHINGTON UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01CA297167"},{"project":"R01CA216840","title":"OVERCOMING THE PROTECTIVE BARRIERS OF BREAST CANCER IN BONE MARROW WITH TARGETED PRODRUG NANOTHERAPY","fiscal_year":2022,"amount_usd":"610502","organization":"WASHINGTON UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01CA216840"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Organ-on-a-chip model of vascularized human bone marrow niches","year":2021,"journal":"Biomaterials","source_url":"https://doi.org/10.1016/j.biomaterials.2021.121245","status":"verified"},{"title":"Breast cancer–derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment","year":2021,"journal":"Journal of Clinical Investigation","source_url":"https://doi.org/10.1172/jci145296","status":"verified"},{"title":"Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth","year":2021,"journal":"iScience","source_url":"https://doi.org/10.1016/j.isci.2021.103012","status":"verified"},{"title":"Retrospective Analysis of Treatment Patterns and Effectiveness of Palbociclib and Subsequent Regimens in Metastatic Breast Cancer","year":2019,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2018.7094","status":"verified"},{"title":"Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance","year":2018,"journal":"Nature Communications","source_url":"https://doi.org/10.1038/s41467-018-03600-6","status":"verified"}],"source":"works"},"contact":{"address_1":"4921 PARKVIEW PL","address_2":"DIV IM MEDICAL ONCOLOGY, STE 7A, 7B, 7C","city":"Saint Louis","state":"MO","zip":"631101032","phone":"800-647-2098","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1447277942","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":23,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-04-17","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}